ReviewFungal diversity2022
Ten decadal advances in fungal biology leading towards human well-being.
Review in Fungal diversity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Contribution of Mycological Tourism to Well-Being, the Economy and Sustainable Development.International journal of environmental research and public health · 2022Pooled it
- L-asparaginase by filamentous fungi and yeasts from lichens and soils across maritime Antarctic islands.Extremophiles : life under extreme conditions · 2026Article
- Crystal Facet-Polysaccharide Matching in CFS-P Nanocrystals Drives Fungal Uptake, Vacuole Destruction, and Selective Antifungal Activity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Structurally diverse secondary metabolites from the dung-inhabiting fungus Botryotrichum murorum.Scientific reports · 2026Article
- Article
- Should describing a new species be science or data release? Rethinking introductions in fungal taxonomy.IMA fungus · 2026Article
- All you need is fungi: Exploring secondary metabolites as a source of novel amoebicidal agents.Genetics and molecular biology · 2026Article
- Olive mill solid waste induces beneficial mushroom-specialized metabolite diversity revealed by computational metabolomics strategies.Metabolomics : Official journal of the Metabolomic Society · 2025Article
- Fungal graviresponses: Physiological and molecular insights from tissue reorientation in the gravity vector.Mycology · 2025Review
- Article
- Article
- Fungi fromFrontiers in cellular and infection microbiology · 2025Article
- IMA fungus · 2025Review
- Hass Avocado (Microorganisms · 2024Article
- Dactylfungins and Tetralones: Bioactive Metabolites from a Nematode-AssociatedJournal of natural products · 2024Article
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Funding for research on cryptococcal disease: an analysis based on the G-finder report.IMA fungus · 2024Article
- Bioprospection of Tenellins Produced by the Entomopathogenic FungusJournal of fungi (Basel, Switzerland) · 2024Article
- Exploring the potential of naturally occurring antimicrobials for managing orthopedic-device-related infections.Journal of bone and joint infection · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
Abstract
Fungi are an understudied resource possessing huge potential for developing products that can greatly improve human well-being. In the current paper, we highlight some important discoveries and developments in applied mycology and interdisciplinary Life Science research. These examples concern recently introduced drugs for the treatment of infections and neurological diseases; application of -OMICS techniques and genetic tools in medical mycology and the regulation of mycotoxin production; as well as some highlights of mushroom cultivaton in Asia. Examples for new diagnostic tools in medical mycology and the exploitation of new candidates for therapeutic drugs, are also given. In addition, two entries illustrating the latest developments in the use of fungi for biodegradation and fungal biomaterial production are provided. Some other areas where there have been and/or will be significant developments are also included. It is our hope that this paper will help realise the importance of fungi as a potential industrial resource and see the next two decades bring forward many new fungal and fungus-derived products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.